In the PCN DES 22/23 Section 8.5.1 d. states that a PCN is required to: “focus on prostate cancer, and informed by data provided by the local Cancer Alliance, develop and implement a plan to increase the proactive and opportunistic assessment of patients for a potential cancer diagnosis in population cohorts where referral rates have not recovered to their prepandemic baseline”.
CCG data regarding 2ww for all suspected urological cancers on ERS is available here. Practices may wish to look at their own referrals for suspected prostate cancer via clinical systems, eg EMIS over the past 5 years to see if referrals dropped over the pandemic and have now recovered.
Our GP colleague Dr Richard Roope, Primary Care advisor for CRUK and RCGP Clinical Advisor describes Prostate Cancer, the new contract, background and FAQs here looking at the current science and evidence, particularly around PSA testing in asymptomatic men and how best to manage this aspect of patient care.
Educational video presented by Mr Mahmood Elfar
Mr Mahmoud Elfar, Consultant Urological Surgeon and Chair of the Urology Care Quality Group at Cheshire & Merseyside Cancer Alliance, gives information on prostate cancer for GPs and other primary care clinicians
Other educational resources around PSA testing and diagnosing prostate cancer
Discuss Your Risk
‘Discuss your risk’ is the message being given to black men in Liverpool who are invited to find out more about their chance of developing prostate cancer.
One in four black men will be diagnosed with prostate cancer in their lifetime – twice the rate of other men in the population – and men whose brother or father have had the disease or their mother or sister has had breast cancer are more likely to develop it, too.
Black men over the age of 45 are being encouraged to check their risk with an online tool – www.prostatecanceruk.org/cmca-risk – and to speak to their local GP surgery to discuss their risk of prostate cancer with a clinician if they are concerned.
Cheshire & Merseyside Cancer Alliance (CMCA) has joined with Prostate Cancer UK (PCUK) to highlight the issue with a local campaign – called Discuss Your Risk – running in March, 2022, Prostate Cancer Awareness Month, with events where black men can find out more information.
Please see the toolkit below for primary care to help you inform your patients and others about this campaign and for more information on the issue.
ITV Granada News broadcast a news story on the campaign, which you can watch here.
OVERVIEW
‘Discuss your risk’ is the message being given to black men in Liverpool who are invited to find out more about their risk of developing prostate cancer.
One in four black men will be diagnosed with prostate cancer in their lifetime – twice the rate of other men in the population – and men whose brother or father has had the disease or their mother or sister has had breast cancer are more likely to develop it, too.
Cheshire & Merseyside Cancer Alliance (CMCA) joined with Prostate Cancer UK (PCUK) to highlight the issue with a local campaign running during March – Prostate Cancer Awareness Month – with events where black men can find out more information.
This toolkit is for primary care organisations, primarily GP practices and Primary Care Networks, and is designed to give accurate information and advice, which they can use to educate and inform black men about their risk of developing prostate cancer and encouraging them to find out about this and to contact their GP surgery to talk to a clinician if they are concerned.
CMCA created this campaign with Prostate Cancer UK, community organisations, local GP surgeries and Central Liverpool and Picton Primary Care Networks.
We would like to thank everyone, especially the organisations above, which supported us.
Section 8.5.1 d. states that a PCN is required to “focus on prostate cancer, and informed by data provided by the local Cancer Alliance, develop and implement a plan to increase the proactive and opportunistic assessment of patients for a potential cancer diagnosis in population cohorts where referral rates have not recovered to their prepandemic baseline”.
CCG data regarding 2ww for all suspected urological cancers on ERS is available here NHS e-Referral Service (e-RS) open data dashboard - NHS Digital. Practices may wish to look at their own referrals for suspected prostate cancer via clinical systems, eg EMIS over the past 5 years to see if referrals dropped over the pandemic and have now recovered.
Our GP colleague Dr Richard Roope, Primary Care advisor for CRUK and RCGP Clinical Advisor describes Prostate Cancer, the new contract, background and FAQ's here looking at the current science and evidence, particularly around PSA testing in asymptomatic men and how best to manage this aspect of patient care.
VIDEO
These videos can be used to inform black men about their prostate cancer risk:
Silent Killer In Black Men, a film dramatising a how an African man learns about his risk of prostate cancer. This short film was premiered at the event on 3rd March 2022 at Kuumba Imani Millennium Centre, Liverpool: https://youtu.be/TUhu54mVePE
Prostate cancer patient Selwyn Sylvester urges men to discuss their risk (CMCA)